+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
From
From
From
From
Leigh Syndrome Treatment - Global Strategic Business Report - Product Thumbnail Image

Leigh Syndrome Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 477 Pages
  • Global
From
Pharmaceutical Drugs Market Report 2025 - Product Thumbnail Image

Pharmaceutical Drugs Market Report 2025

  • Report
  • March 2025
  • 400 Pages
  • Global
From
From
From
From
From
Interferons Market 2025-2029 - Product Thumbnail Image

Interferons Market 2025-2029

  • Report
  • May 2025
  • 212 Pages
  • Global
From
From
Large Molecule Injectable Drugs Market 2024-2028 - Product Thumbnail Image

Large Molecule Injectable Drugs Market 2024-2028

  • Report
  • July 2024
  • 166 Pages
  • Global
From
Precision Medicine - Global Strategic Business Report - Product Thumbnail Image

Precision Medicine - Global Strategic Business Report

  • Report
  • July 2025
  • 279 Pages
  • Global
From
From
Biobetters Market - Growth, Trends, and Forecast(2022 - 2027) - Product Thumbnail Image

Biobetters Market - Growth, Trends, and Forecast(2022 - 2027)

  • Report
  • January 2022
  • 115 Pages
  • Global
From
Loading Indicator